Author

Balakrishna Lakhavath

OpenAlex ID: A5069005201

Abstract A099: Best in class, potent, SOS1 inhibitors demonstrate single agent activity in preclinical models of KRAS driven tumors

2023 · Balakrishna Lakhavath, Manoj Pothuganti, et al. · Molecular Cancer Therapeutics

Abstract 6368: Discovery of potent, orally bioavailable, SOS1 inhibitors for KRAS-driven tumors

2022 · Sanjita Sasmal, Sukanya Patra, et al. · Cancer Research

Works count: 2

Citation count:

H-index:

I10-index: